Wockhardt Limited · NSE:WOCKPHARMA

Wockhardt — Investor Presentation (May 2013)

26 slides from Wockhardt's investor presentation, May 2013

  1. Slide 1: Wockhardt Limited Investor Presentation

    Slide 1: Wockhardt Limited Investor Presentation

    Wockhardt Limited Investor Presenta,on By Dr. Murtaza Khorakiwala Managing Director May 2013

  2. Slide 2: Safe Harbor Statement

    Slide 2: Safe Harbor Statement

    Safe Harbor Statement • Except for historical informa,on contained herein, statements in this communica,on, which include words or phrases such as “will”, “aim”, “will likely result”, “would”, “believe”, “may”, “expect”, “will con,nue”, “an,cipate”, “es,mate”, “intend”, “plan”, “contemplate”, “seek

  3. Slide 3: Introduction to Wockhardt: Key Business Dynamics

    Slide 3: Introduction to Wockhardt: Key Business Dynamics

    Introduc4on to Wockhardt Key Business Dynamics

  4. Slide 4: Wockhardt Today

    Slide 4: Wockhardt Today

    Wockhardt Today UK, Ireland, France, Switz. USA Direct Opera4ons in India, USA Mexico India and Europe 7900 Associates employed in 21 countries Wockhardt Direct ROW opera4ons opera4ons Investor Presenta4on May 2013 4

  5. Slide 5: Wockhardt Today: Manufacturing Locations

    Slide 5: Wockhardt Today: Manufacturing Locations

    Wockhardt Today UK Ireland 9 sites Chicago in India Baddi 12 Manufacturing Loca4ons globally Ankleshwar Daman (2 Plants) Aurangabad (5 Plants) Formula,ons APIs Investor Presenta4on May 2013 5

  6. Slide 6: Wockhardt Today: R&D Centers

    Slide 6: Wockhardt Today: R&D Centers

    Wockhardt Today 3 R&D Centers worldwide USA / UK & India Investor Presenta4on May 2013 6

  7. Slide 7: FY13 / Q4 Results

    Slide 7: FY13 / Q4 Results

    FY13 / Q4 Results TWOCKHARDI

  8. Slide 8: FY13 & Q4 Results - Note

    Slide 8: FY13 & Q4 Results - Note

    FY13 & Q4 Results -­‐ Note • The results discussed in the following slides have been normalized for the following for all the previous compara,ve periods 1. Nutri,on Business Revenues and Profits and 2. Research & Development Costs Investor Presenta4on May 2013 8

  9. Slide 9: FY13 Results (Annual)

    Slide 9: FY13 Results (Annual)

    FY13 Results (Annual) TWOCKHARDI

  10. Slide 10: Sales – Growth of 29% over FY12

    Slide 10: Sales – Growth of 29% over FY12

    Sales – Growth of 29% over FY12 Rs.crore Growth of 29% in FY13 over FY12 Investor Presenta4on May 2013 10

  11. Slide 11: EBITDA – Growth of 60% over FY12

    Slide 11: EBITDA – Growth of 60% over FY12

    EBITDA – Growth of 60% over FY12 Rs.crore Growth of 60% in FY13 over FY12 Investor Presenta4on May 2013 11

  12. Slide 12: Adj. PAT Growth of 100% over FY12

    Slide 12: Adj. PAT Growth of 100% over FY12

    Adj. PAT Growth of 100% over FY12 Rs.crore Growth of 100% in FY13 over FY12 Investor Presenta4on May 2013 12

  13. Slide 13: Research

    Slide 13: Research

    Research Investor Presenta4on May 2013 13

  14. Slide 14: Strong Balance Sheet

    Slide 14: Strong Balance Sheet

    Strong Balance Sheet Rs.crore Investor Presenta4on May 2013 14

  15. Slide 15: Stronger Financial Parameters

    Slide 15: Stronger Financial Parameters

    Stonger Financial Parameters Investor Presenta4on May 2013 15

  16. Slide 16: Financial Highlights

    Slide 16: Financial Highlights

    Financial Highlights • Free Cash Flow from opera,ons over Rs. 1,400 Crores for FY2013 (before capex and loan repayment). • Exit from CDR on target. • Total Debt (including Preference shares redemp,on) repaid during the year in excess of Rs.1,800 Crores. • Net interest cost stand at around 4.6% on an

  17. Slide 17: Q4FY13 Results

    Slide 17: Q4FY13 Results

    Q4AFY13 Results TWOCKHARDI

  18. Slide 18: Sales – Growth of 26% over Q4FY12

    Slide 18: Sales – Growth of 26% over Q4FY12

    Sales – Growth of 26% over Q4FY12 Growth of 26% over Q4FY12 Investor Presenta4on May 2013 18

  19. Slide 19: EBITDA – Growth of 37% over Q4FY12

    Slide 19: EBITDA – Growth of 37% over Q4FY12

    EBITDA – Growth of 37% over Q4FY12 Growth of 37% over Q4FY12 13th Consecu4ve Quarter of Sequen4al Growth Investor Presenta4on May 2013 19

  20. Slide 20: Adj. PAT – Stable Growth

    Slide 20: Adj. PAT – Stable Growth

    Adj. PAT – Stable Growth Growth of 1% in Q4FY13 over Q4FY12 Investor Presenta4on May 2013 20

  21. Slide 21: US Business: Profitable Growth

    Slide 21: US Business: Profitable Growth

    US Business: Profitable Growth • Growth of 52% (30% on $terms) over FY12. • 12 New Products launched in FY13. • 20 ANDAs filed during the year • 46 ANDAs pending approval. • Growth driven by niche launches made during the year • 18 products in US market at no.1 position and 17 products at no.2 positi

  22. Slide 22: EU Operations: Strong UK Operations

    Slide 22: EU Operations: Strong UK Operations

    EU Opera,ons: Strong UK Opera,ons UK Operations • UK operation grows by 24% (8% in £ terms) in FY13 against a stagnant market growth • 13 new product launches in FY13 of which 2 products being Day 1 launches • 16 new product filings in FY13. • No. 3 Generic company in UK • No. 2 in the hospital segm

  23. Slide 23: Emerging Markets

    Slide 23: Emerging Markets

    Emerging Markets • Emerging Markets growth at 12% for FY2013. • Indian Business grew at 8% over FY12. • Restructuring of the India field force has been completed. • 21 new products were introduced in the Indian market, • ROW operations grew by 24% over FY12. • Mexico operations commenced. Investor P

  24. Slide 24: Consistent Profitable Growth

    Slide 24: Consistent Profitable Growth

    Consistent Profitable Growth

  25. Slide 25: Delivering Consistent Profits

    Slide 25: Delivering Consistent Profits

    Delivering Consistent Profits • R&D at the Strategic Core Research • Robust Product Pipeline • Direct Opera,ons in USA, UK , Ireland & India Globaliza,on • Strategic Alliances in Emerging Economies • Strong Management & Research Capabili,es Opera,onal • Focus on High Value Product Launches Excellence

  26. Slide 26: For investor updates please visit www.wockhardt.com

    Slide 26: For investor updates please visit www.wockhardt.com

    For investor updates and communica4on please visit www.wockhardt.com For Informa,on please contact Tushar Mistry Tel.: +91 22 26596210 tmistry@wockhardt.com Investor Presenta,on May 2013 26

Source: Internet Archive copy of wockhardt.com

More decks from Wockhardt Limited

All 22 Wockhardt decks